International $ 223.21 Billion Oncology Medicine Markets to 2031 with F. Hoffmann-La Roche, Novartis, Gilead Sciences, Bayer and Takeda Pharmacueticals Dominating

Firm Emblem

International Oncology Medicine Market

Global Oncology Drugs Market

International Oncology Medicine Market

Dublin, June 21, 2022 (GLOBE NEWSWIRE) – The “Oncology Medicine International Market Report 2022, By Sort, Drug Sort, Drug Classification” report has been added to’s providing.

The worldwide oncology medication market is anticipated to develop from $ 199.95 billion in 2021 to $ 223.21 billion in 2022 at a compound annual development price (CAGR) of 11.6%. The market is anticipated to achieve $ 328.22 billion in 2026 at a CAGR of 10.1%.

Main firms within the oncology medication market embody F.Hoffmann-La Roche Ltd., Novartis AG, Gilead Sciences Inc., Bayer AG and Takeda Prescribed drugs.

North America was the most important area within the oncology medication market in 2021. The Center East is anticipated to be the quickest rising area within the forecast interval.

The oncology medication market consists of gross sales of oncology medication and associated companies by entities (organizations, sole merchants and partnerships) that produce oncology medication to diagnose and deal with all forms of cancers.

Firms within the oncology market are more and more investing in applied sciences equivalent to synthetic intelligence (AI) to avoid wasting time and cut back analysis and growth prices. AI is the simulation of human intelligence processes by machines, particularly pc programs, which has the potential to surpass human intelligence ranges.

This expertise helps to investigate massive units of chemical and organic information to establish potential drug candidates with increased success charges and at a faster tempo when in comparison with human evaluation. The expertise additionally helps in rushing up the affected person recruitment course of by matching most cancers sufferers with essentially the most related medical trials, thus reducing medical trial prices.

Main oncology drug producers equivalent to Roche, Pfizer and Johnson and Johnson have already invested in AI applied sciences to cut back time taken and prices incurred for drug growth. For instance, Johnson and Johnson have not too long ago entered into an settlement with BenevolentAI, a UK-based start-up, to mine information for designing new oncology medication.

Firms within the oncology drug market are investing in focused remedy, which has confirmed to be much less poisonous in comparison with conventional therapy choices. Focused most cancers therapies are medication or substances that block the expansion of most cancers by interfering with molecules which might be extra particularly concerned in most cancers cell development than in regular cell exercise.

The objective of those therapies is to get rid of cancerous cells within the physique whereas leaving regular cells unhurt. By specializing in adjustments within the cell which might be particular to most cancers, this remedy might show to be more practical than conventional chemotherapy and radiotherapy.

Firms within the oncology market equivalent to Pfizer, Novartis and Abbvie have understood the significance of this therapy technique and are more and more investing in it. In response to a report by QuintilesIMS, 87% of the medication presently in pipeline represent of focused remedy medication.

Key Subjects Lined:

1. Govt Abstract

2. Report Construction

3. Oncology Medicine Market Traits
3.1. Market Definition
3.2. Key Segments

4. Oncology Medicine Market Product Evaluation
4.1. Main Merchandise / Companies
4.2. Key Options and Differentiators
4.3. Improvement Merchandise

5. Oncology Medicine Market Provide Chain
5.1. Provide Chain
5.2. Distribution
5.3. Finish Prospects

6. Oncology Medicine Market Buyer Data
6.1. Buyer Preferences
6.2. Finish Use Market Dimension and Development

7. Oncology Medicine Market Developments And Methods

8. Impression Of COVID-19 On Oncology Medicine

9. Oncology Medicine Market Dimension And Development
9.1. Market Dimension
9.2. Historic Market Development, Worth ($ Billion)
9.2.1. Drivers Of The Market
9.2.2. Restraints On The Market
9.3. Forecast Market Development, Worth ($ Billion)
9.3.1. Drivers Of The Market
9.3.2. Restraints On The Market

10. Oncology Medicine Market Regional Evaluation
10.1. International Oncology Medicine Market, 2021, By Area, Worth ($ Billion)
10.2. International Oncology Medicine Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Area
10.3. International Oncology Medicine Market, Development And Market Share Comparability, By Area

11. Oncology Medicine Market Segmentation
11.1. International Oncology Medicine Market, Segmentation By Sort, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Pharmaceutical Medicine

  • Biologics

11.2. International Oncology Medicine Market, Segmentation By Drug Sort, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Chemotherapy

  • Harmone Remedy

  • Focused Remedy

  • Lung Most cancers

  • Pancreatic Most cancers

  • Breast Most cancers

  • Prostate Most cancers

  • Ovarian Most cancers

  • Colorectal Most cancers

  • Gastric Most cancers

  • Kidney Most cancers

  • Mind Tumor

  • Thyroid Most cancers

  • Pores and skin Most cancers

  • Bladder Most cancers

  • Cervical Most cancers

  • Blood Most cancers

  • Others (Kaposi Sarcoma, AIDS-Associated Lymphoma, Anal Most cancers, Bone Most cancers, Retinoblastoma, Testicular Most cancers, Hepatocellular (Liver) Most cancers, Mouth Most cancers, Neuroblastoma)

11.3. International Oncology Medicine Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11.4. International Oncology Medicine Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11.5. International Oncology Medicine Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Branded Medicine

  • Generic Medicine

12. Oncology Medicine Market Metrics
12.1. Oncology Medicine Market Dimension, Proportion Of GDP, 2016-2026, International
12.2. Per Capita Common Oncology Medicine Market Expenditure, 2016-2026, International

Firms Talked about

  • F.Hoffmann-La Roche Ltd.

  • Novartis AG

  • Gilead Sciences Inc.

  • Bayer AG

  • Takeda Pharmaceticals

For extra details about this report go to


CONTACT: CONTACT: Laura Wooden, Senior Press Supervisor For E.S.T Workplace Hours Name 1-917-300-0470 For U.S./CAN Toll Free Name 1-800-526-8630 For GMT Workplace Hours Name +353-1-416-8900

Leave a Comment